Clinical Trial: Inflammatory Breast Cancer (IBC) Registry

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational

Official Title: Inflammatory Breast Cancer (IBC) Registry

Brief Summary: The goal of this research study is to collect blood and tissue samples and clinical data from patients with IBC or highly suspicious for IBC. The blood and tissue samples and clinical data will be stored in a research tissue bank and used to help researchers try to better understand IBC.

Detailed Summary:

IBC:

IBC is a rare but rapidly growing form of breast cancer. Currently, there are no known risk factors and biological features (such as in the genes) that researchers can use to help design better treatments for IBC.

Study Participation:

If you are diagnosed with IBC or the doctor believes that you may have IBC, you will be asked to participate in this IBC registry study. This registry study is to collect data, blood and tissue for future studies.

• For patients who have never received treatment for IBC or have breast condition which the doctor believes may be IBC : You will have a core, breast tissue, and skin biopsy. If lymph nodes are noticed during the core biopsy, lymph nodes core biopsy or final needle aspiration will be done as well. To perform a core, breast tissue, and skin biopsy, an affected area of skin is numbed with anesthetic, and a small amount of skin tissue is removed with a small knife. This is a fresh sample collected for diagnosis and for the study.
• You will have additional blood (about 4 tablespoons) drawn for this study, during a routine blood draw. The additional blood will not be drawn if you do not have IBC.
• For patients who have received treatment for IBC: Your original biopsy sample and/or breast surgery tissue sample will be collected for diagnosis (if needed by your doctor) and for the study.
• You will have an interview. During this interview, you will be asked questions about your medical history as well as general background information. The interview will be conducted by the study chair or their designee in the examination room and after the meeting with the
  Sponsor: M.D. Anderson Cancer Center
  

  Current Primary Outcome: Number of patients with untreated newly diagnosed IBC participating in Registry [ Time Frame: 6 Years ]
  
  

  Original Primary Outcome:
  
  

  Current Secondary Outcome:
  
  

  Original Secondary Outcome:
  
  Information By: M.D. Anderson Cancer Center
  

  Dates:
  Date Received: May 18, 2007
  Date Started: April 2007
  Date Completion:
  Last Updated: January 3, 2017
  Last Verified: January 2017